Skip to main content

Perrigo board okays separation of prescription pharma business

Perrigo Company Plc said on Thursday its board approved a plan to separate its Prescription Pharmaceuticals (Rx) business after the generic drugmaker completed a review of its strategic portfolio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.